In total, five out of 23 patients had adverse events, including one mild anemia, one GI discomfort, one wheal response, and two liver injury (ALT less than three times the upper limit of normal), which all have been reported in previous RA studies (12, 52). This evidence concerns the gene GPT and anemia.